SCHEMBL16974865

SCHEMBL16974865

Clc1ccc2c(c1)NC(NCCc1ccccn1)=NS2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
CYP1A2 P05177 2/20 0.43
CNR1 P21554 1/20 0.42
LMNA P02545 2/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
NOX1 Q9Y5S8 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16974905 0.88 ALDH1A1 (0.46) CYP1A2BCHEACHENOX1SMN1; SMN2
SCHEMBL16974835 0.87 CYP1A2 (0.47) PKMCYP1A2CNR1LMNASMN1; SMN2
SCHEMBL8664923 0.86 CYP1A2 (0.43) PKMCYP1A2LMNASMN1; SMN2ALDH1A1
SCHEMBL16974908 0.83 CYP1A2 (0.42) PKMCYP1A2CNR1LMNASMN1; SMN2
SCHEMBL16974849 0.83 CYP1A2 (0.44) PKMCYP1A2LMNASMN1; SMN2ALDH1A1
SCHEMBL16974883 0.80 KDM4E (0.39) BCHEACHENOX1SMN1; SMN2KDM4E
SCHEMBL16974823 0.79 ALDH1A1 (0.46) PKMCYP1A2BCHEACHESMN1; SMN2
SCHEMBL16974854 0.79 HDAC8 (0.41) BCHEACHENOX1SMN1; SMN2KDM4E
SCHEMBL7954366 0.76 PKM (0.48) PKMCYP1A2CNR1LMNASMN1; SMN2
SCHEMBL8585833 0.76 CYP1A2 (0.39) CYP1A2LMNABCHEACHENOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099304-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA Mayo Foundation for Medical Education and Research (US) 2016-12-07 EP disclosed
WO-2015117024-A1 NOVEL THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-08-06 WO disclosed